Atai Life Sciences N.V.

NASDAQ:ATAI

1.08 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 34.33323.86745.03476.492141.09185.885190.613142.53984.132123.975362.266430.308453.622104.36997.246-30.062
Short Term Investments 69.01387.379109.223132.50286.40263.99882.496161.518228.354210.9390000060.124
Cash and Short Term Investments 103.346111.246154.257208.994227.492249.883273.109304.057312.486334.914362.266430.308453.622104.36997.24630.062
Net Receivables 12.0762.4652.2571.5199.0218.8515.6315.3525.97.0970.9133.3861.34424.4861.2910
Inventory 000000-5.6316.7063.95.38611.1477.7042.5092.1990.4570
Other Current Assets 2.4863.78929.0786.8316.2579.19914.0361.3671.3221.3890.7560.4610.1110.0650.5540
Total Current Assets 117.908117.5185.592217.344242.77267.933287.145317.482323.608348.786375.082441.859457.586131.11999.54830.062
Non-Current Assets:
Property, Plant & Equipment, Net 1.9162.0352.2042.252.412.6030.9280.7280.3030.1780.1490.1380.3310.140.0710
Goodwill 0000000000000000
Intangible Assets 0000000000000000
Goodwill and Intangible Assets 0000000000000000
Long Term Investments 93.522147.012102.96275.173.9915.8466.7558.49810.39520.33627.75936.15842.7737.1128.0440
Tax Assets 0000000000000000
Other Non-Current Assets 2.4322.5742.7213.4564.4244.33510.61315.88914.6314.43211.1765.9545.2716.893.885-30.062
Total Non-Current Assets 97.87151.621107.88690.87610.82512.78418.29625.11525.32834.94639.08442.2548.37514.14212-30.062
Total Assets 215.778269.121293.478308.22253.595280.717305.441342.597348.936383.732414.166484.109505.961145.261111.5480
Liabilities & Equity:
Current Liabilities:
Account Payables 3.8143.8434.5895.5063.8594.9152.3993.5112.7383.6126.0041.9746.2027.0313.0830
Short Term Debt 0.2390.2440.2750.2920.3220.317000000.0380.0391.26500
Tax Payables 0.3460.6950.7150.8870.8081.8822.2246.6776.887.7818.1375.9271.3232.4990.9970
Deferred Revenue -4.053-4.0870.71513.00812.8550000000.180.120.1200
Other Current Liabilities 17.64415.01314.5410.8890.8915.63917.49822.40219.21918.47914.93113.1257.82410.6479.2150
Total Current Liabilities 17.64415.01320.1219.69517.92620.87119.89725.91321.95722.09120.93515.31714.18519.06312.2980
Non-Current Liabilities:
Long Term Debt 16.50615.29915.21116.37716.38316.3915.11715.0010.6190.7250.7430.81.1761.72.1770
Deferred Revenue Non-Current 0000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000
Other Non-Current Liabilities 13.09515.55213.8313.6363.649239.641265.4015.6036.2386.559383.4375.2325.7054.5051.7050
Total Non-Current Liabilities 29.60130.85129.04220.01320.032256.031280.51820.6046.8577.284384.186.0326.8816.2053.8820
Total Liabilities 47.24545.86449.16239.70837.958276.902300.41546.51728.81429.375405.11521.34921.06625.26816.180
Equity:
Preferred Stock 0000000000000000
Common Stock 18.76518.618.57318.57118.57118.57118.56218.55418.11418.00718.00217.8717.29915.25313.3720
Retained Earnings -634.963-577.651-550.938-532.647-576.891-543.849-510.188-465.178-431.29-394.672-357.803-268.926-237.768-189.307-189.9950
Accumulated Other Comprehensive Income/Loss -19.171-18.925-19.46-19.109-20.818-20.823-21.702-25.788-21.191-12.709-8.336-5.2333.9371.9775.81958.751
Other Total Stockholders Equity 803.259800.52794.787799.461791.688546.101774.068761.811746.042735.38725.045709.475691.382283.467261.6261.029
Total Shareholders Equity 167.89222.544242.962266.276212.55-546.101260.74289.399311.675346.006376.908453.186474.85111.3990.82259.78
Total Equity 168.533223.257244.316268.512215.637-542.286265.766296.08320.122354.357385.959462.76484.895119.99395.36859.78
Total Liabilities & Shareholders Equity 215.778269.121293.478308.22253.595280.717305.441342.597348.936383.732414.166484.109505.961145.261111.54859.78